209 related articles for article (PubMed ID: 10400711)
41. Proteolytic processing of a Murray Valley encephalitis virus non-structural polyprotein segment containing the viral proteinase: accumulation of a NS3-4A precursor which requires mature NS3 for efficient processing.
Lobigs M
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2305-12. PubMed ID: 1328486
[TBL] [Abstract][Full Text] [Related]
42. The N-terminal region (VP4) of the foot-and-mouth disease capsid precursor (P1-2A) is not required during its synthesis to allow subsequent processing by the 3C protease.
Kristensen T; Normann P; Belsham GJ
Virology; 2022 May; 570():29-34. PubMed ID: 35364457
[TBL] [Abstract][Full Text] [Related]
43. The unique role of domain 2A of the hepatitis A virus precursor polypeptide P1-2A in viral morphogenesis.
Morace G; Kusov Y; Dzagurov G; Beneduce F; Gauss-Muller V
BMB Rep; 2008 Sep; 41(9):678-83. PubMed ID: 18823593
[TBL] [Abstract][Full Text] [Related]
44. Stimulation of poliovirus proteinase 3Cpro-related proteolysis by the genome-linked protein VPg and its precursor 3AB.
Molla A; Harris KS; Paul AV; Shin SH; Mugavero J; Wimmer E
J Biol Chem; 1994 Oct; 269(43):27015-20. PubMed ID: 7929442
[TBL] [Abstract][Full Text] [Related]
45. Autoproteolytic cleavage of recombinant 3C proteinase of hepatitis A virus.
Gauss-Müller V; Jürgensen D; Deutzmann R
Virology; 1991 Jun; 182(2):861-4. PubMed ID: 1850933
[TBL] [Abstract][Full Text] [Related]
46. A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor.
Blair WS; Li X; Semler BL
J Virol; 1993 Apr; 67(4):2336-43. PubMed ID: 8383245
[TBL] [Abstract][Full Text] [Related]
47. Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP.
Das S; Dasgupta A
J Virol; 1993 Jun; 67(6):3326-31. PubMed ID: 8388502
[TBL] [Abstract][Full Text] [Related]
48. Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
Jewell JE; Ball LA; Rueckert R
J Virol; 1990 Mar; 64(3):1388-93. PubMed ID: 2154618
[TBL] [Abstract][Full Text] [Related]
49. Proteolytic processing of the coronavirus infectious bronchitis virus 1a polyprotein: identification of a 10-kilodalton polypeptide and determination of its cleavage sites.
Liu DX; Xu HY; Brown TD
J Virol; 1997 Mar; 71(3):1814-20. PubMed ID: 9032311
[TBL] [Abstract][Full Text] [Related]
50. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV.
Bergmann EM; Cherney MM; Mckendrick J; Frormann S; Luo C; Malcolm BA; Vederas JC; James MN
Virology; 1999 Dec; 265(1):153-63. PubMed ID: 10603326
[TBL] [Abstract][Full Text] [Related]
51. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation.
Bartenschlager R; Lohmann V; Wilkinson T; Koch JO
J Virol; 1995 Dec; 69(12):7519-28. PubMed ID: 7494258
[TBL] [Abstract][Full Text] [Related]
52. Expression and characterization of recombinant hepatitis A virus 3C proteinase.
Malcolm BA; Chin SM; Jewell DA; Stratton-Thomas JR; Thudium KB; Ralston R; Rosenberg S
Biochemistry; 1992 Apr; 31(13):3358-63. PubMed ID: 1313294
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites.
Grakoui A; McCourt DW; Wychowski C; Feinstone SM; Rice CM
J Virol; 1993 May; 67(5):2832-43. PubMed ID: 8386278
[TBL] [Abstract][Full Text] [Related]
54. In vitro and ex vivo inhibition of hepatitis A virus 3C proteinase by a peptidyl monofluoromethyl ketone.
Morris TS; Frormann S; Shechosky S; Lowe C; Lall MS; Gauss-Müller V; Purcell RH; Emerson SU; Vederas JC; Malcolm BA
Bioorg Med Chem; 1997 May; 5(5):797-807. PubMed ID: 9208091
[TBL] [Abstract][Full Text] [Related]
55. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles.
Anderson DA; Ross BC
J Virol; 1990 Nov; 64(11):5284-9. PubMed ID: 2170672
[TBL] [Abstract][Full Text] [Related]
56. Assembly and characterization of foot-and-mouth disease virus empty capsid particles expressed within mammalian cells.
Gullberg M; Muszynski B; Organtini LJ; Ashley RE; Hafenstein SL; Belsham GJ; Polacek C
J Gen Virol; 2013 Aug; 94(Pt 8):1769-1779. PubMed ID: 23740480
[TBL] [Abstract][Full Text] [Related]
57. Cleavage sites within the poliovirus capsid protein precursors.
Larsen GR; Anderson CW; Dorner AJ; Semler BL; Wimmer E
J Virol; 1982 Jan; 41(1):340-4. PubMed ID: 6283126
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis in Albanian children: molecular analysis of hepatitis A virus isolates.
Gabrieli R; Sanchez G; Macaluso A; Cenko F; Bino S; Palombi L; Buonomo E; Pinto RM; Bosch A; Divizia M
J Med Virol; 2004 Apr; 72(4):533-7. PubMed ID: 14981754
[TBL] [Abstract][Full Text] [Related]
59. Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites.
Chambers TJ; Grakoui A; Rice CM
J Virol; 1991 Nov; 65(11):6042-50. PubMed ID: 1833562
[TBL] [Abstract][Full Text] [Related]
60. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.
Harris KS; Reddigari SR; Nicklin MJ; Hämmerle T; Wimmer E
J Virol; 1992 Dec; 66(12):7481-9. PubMed ID: 1331532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
